Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of tre...

Full description

Saved in:
Bibliographic Details
Main Author Megiddo, Dalia
Format Patent
LanguageEnglish
Published 22.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.
AbstractList Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.
Author Megiddo, Dalia
Author_xml – fullname: Megiddo, Dalia
BookMark eNqNzEsKwjAUheEMdOBrD9cFCNaC1KmiOLeOy7U5TQPtTUii4O4N6AIcncF_-OZqIk4wU7EO4DRCErmOfHAJVoiNCTCcrBMa385z6m1LLJoEz-A0DAQh9xdI2wiOiPR4k-eQpVwGYj1asTGFr5LxFNDz4CKWatrxELH67UKtL-f6dN3AuwbRc5v11NxvxbbaH6qyOO7Kfz4feE1H3w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US10869831B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10869831B23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:55:32 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10869831B23
Notes Application Number: US201916460046
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201222&DB=EPODOC&CC=US&NR=10869831B2
ParticipantIDs epo_espacenet_US10869831B2
PublicationCentury 2000
PublicationDate 20201222
PublicationDateYYYYMMDD 2020-12-22
PublicationDate_xml – month: 12
  year: 2020
  text: 20201222
  day: 22
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Seelos Therapeutics, Inc
RelatedCompanies_xml – name: Seelos Therapeutics, Inc
Score 3.3123581
Snippet Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201222&DB=EPODOC&locale=&CC=US&NR=10869831B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwjSt-Kadto8FGHtxhD2gdtkbyNp2jqZ7Vgrsv_eXOicPuhbSOC4HNxHcne_A7gVsW2LOLTMB5tx01EO2HSbVJhMSipCwRpMYqNwr3_fnThP0-a0Am-bXhiNE_qpwRGVRoVK3wttr5fbT6xA11bmd2KutrLHztgLjPJ1TDFRRI2g5bWHg2DgG77vTUZG_9nDgULMta2WMtc7GEYjzn77pYVdKcufLqVzCLtDRS0tjqASpTXY9zeT12qw1ysT3mpZ6l5-DPl4UxNOsphofIV5SniiHsyJ5pi8rzM9YDgkPJVEI1XKKNG40mjUSJmMyYlYEyw8R5nyBeG_8HOReLGKXvkiy6MTuOm0x37XVNzPvkU1m4y2F7VPoZpmaXQGxOEWbfDYopwJB-F8hIobQukyt8EEd-Q51P-mU__v8AIOUOxY4EHpJVSL1Ud0pdx0Ia61fL8AWXSbLg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokbwqyZmb4usG7I-LCZsEFS-IsPwRtp1QwxuhM0Y_nvbZog-6FvTJpf2mrvr9e5-B3DDItNkUWDoDZNQ3RIGWLfrmOmEc8wCRmqEy0LhXv-uM7YeJ_VJAd42tTAKJ_RTgSMKiQqEvGdKXy-3n1ieyq1Mb9lcTCX3bd_xtNw7xjJQhDWv6bSGA2_gaq7rjEda_9mRDYWIbRpNoa53GsIlVK7SS1NWpSx_mpT2AewOBbU4O4RCGJeh5G46r5Vhr5cHvMUwl730CFJ_kxOOkggpfIV5jOhMOMwztWP0vk5Ug-EA0ZgjhVTJw5nClZZKDeXBmBSxNZKJ55KndIHoL_xcSTxbha90kaThMVy3W77b0cXup9-smo5H24OaJ1CMkzg8BWRRA9doZGBKmCXhfJh4NwTcJnaNMGrxClT_plP9b_EKSh2_1512H_pPZ7Avr0Ame2B8DsVs9RFeCJOdsUvF6y_BHZ4Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Treatment+of+protein+aggregation+myopathic+and+neurodegenerative+diseases+by+parenteral+administration+of+trehalose&rft.inventor=Megiddo%2C+Dalia&rft.date=2020-12-22&rft.externalDBID=B2&rft.externalDocID=US10869831B2